«Nasopharyngeal

Below is an extended Nasopharyngeal patents listing. Click here to return to the Nasopharyngeal main in depth entry.

Patents :
US Patent No.	Title
7396827	Pharmaceutical compositions and treatment methods
7407967	Cyclopamine analogues and methods of use thereof
7407973	Use of pirfenidone in therapeutic regimens
7410642	Assays and therapies for latent viral infection
7410645	Moraxella (Branhamella) catarrhalis antigens
7410648	Polypeptides of Moraxella (Branhamella) catarrhalis
7410975	Small molecule toll-like receptor (TLR) antagonists
7411051	Antibodies to HDPPA04 polypeptide
7411058	Cold-adapted equine influenza viruses
7412284	Apparatus for electroporation mediated delivery for drugs and genes
7412285	Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
7407664	Peptide vaccines against group A streptococci
7406966	Method and device for non-invasive ventilation with nasal interface
7405227	Treatment of cancer
7396838	Use of 1H-indol-3-yl-2-oxoacetamide compounds
7399460	Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
7399477	Cold-adapted equine influenza viruses
7399613	Sialic acid nucleotide sugars
7399754	N.sup.2-quinoline or isoquinoline substituted purine derivatives
7399829	Variants of RANKL protein
7399840	Proteosome influenza vaccine
7402309	Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions
7402574	Antisense composition and method for treating cancer
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7413851	Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7415358	Molecular toxicology modeling
7425327	Choline binding proteins for anti-pneumococcal vaccines
7425611	Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use
7426441	Methods for determining renal toxins
7427471	Modified "S" antibodies
7427479	Methods and kits for identifying target nucleotides in mixed populations
7427495	Methods of using Bcl-2 for the therapeutic treatment and prevention of diseases
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7429584	Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders
7429595	Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7424370	Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
7423125	Antibodies to VEGF-C
7423015	Antihelminthic drugs as a treatment for hyperproliferative diseases
7416539	Powered surgical apparatus, method of manufacturing powered surgical apparatus, and method of using powered surgical apparatus
7417023	Targeted delivery of bioaffecting compounds for the treatment of cancer
7419807	Chlamydia protein, gene sequence and uses thereof
7419808	Methods and compositions for the production of adenoviral vectors
7419817	Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
7419963	Indole antiviral compositions and methods
7420066	Benzofuran derivatives useful for treating hyper-proliferative disorders
7422741	VEGFR-3 fusion proteins
7422899	Antibodies to the human prolactin receptor
7423007	Cxcr4 antagonist and use thereof
7429656	Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.